※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
고해상도 용융(HRM) 분석 시장 성장과 동향
Grand View Research Inc.의 최신 보고서에 따르면, 전 세계 고해상도 용융 분석 시장 규모는 2030년까지 3억 7,580만 달러에 달할 것이며, 2025년부터 2030년까지 2.7%의 CAGR로 성장할 것으로 예상됩니다.
암, 겸상 적혈구빈혈, HIV, 기타 성병의 증가로 인해 스마트하고 간편한 분자진단에 대한 수요가 증가할 것으로 예상됩니다.
질병 동향 분석과 상대적으로 낮은 치료율로 인해 유전자 변이 및 기타 유전체 검사에 대한 수요는 향후 몇 년 동안 크게 증가할 것으로 예상되며, QPCR, 차세대 염기서열 분석, 유전체학, 빅데이터 분석 부문의 최근 동향은 정밀의료 접근법을 강화하는 데 도움이 되고 있습니다. 미국 FDA는 이미 특정 유전자 구성 및 환자의 종양 유전체 프로파일에 대한 요구 사항을 충족하도록 설계된 치료법 중 일부를 승인했습니다.
예를 들어, 미국 FDA는 2012년 1월에 낭포성섬유증(CF)의 새로운 치료제를 승인했습니다. 칼리데코는 'G551D 돌연변이'로 알려진 특정 유전자 돌연변이가 있는 것으로 보고된 환자들에게 승인되었으며, CF를 유발하는 돌연변이의 수는 수백 개에 달하고, G551D 돌연변이는 미국 내 CF 환자의 약 4%를 차지합니다.
또한 2015년 오바마 행정부는 2016년 대통령 예산으로 2억 1,600만 달러를 투자하는 정밀의학 이니셔티브를 발표했습니다. 이 이니셔티브는 예측 기간 동안 HRM 분석 시장을 적극적으로 강화할 것으로 예상됩니다.
고해상도 용융 분석 시장 보고서 하이라이트
- 임상 진단은 2025-2030년 CAGR 3.1%로 가장 빠르게 성장할 것으로 예측됩니다.
- 후천적 돌연변이 검출/돌연변이 스캔/SNP 타이핑 부문이 2024년 가장 높은 매출 점유율을 차지했습니다.
- 2024년 북미는 전체 HRM 분석 시장에서 약 36.0%의 점유율을 차지했습니다. 주요 요인으로는 높은 질병 유병률, 다수의 학술 대학, 강력한 제약 및 생명공학 산업, 다수의 유전자 검사 센터, 의료 성과를 개선하기 위한 신기술의 빠른 채택 등이 있습니다.
- 아시아태평양의 고해상도 용융 분석 시장은 예측 기간 동안 가장 빠른 CAGR 4.9%로 성장할 것으로 예상됩니다. 이는 이 지역의 높은 인구 증가와 암 및 기타 만성질환의 증가로 인해 미충족 의료 수요가 증가하고 있기 때문입니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 고해상도 용융 분석 시장 변수, 동향, 범위
- 시장 계통 전망
- 시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 비즈니스 환경 분석
- 산업 분석 - Porter's Five Forces 분석
- PESTLE 분석
제4장 고해상도 용융 분석 시장 : 제품별, 비즈니스 분석
- 제품 시장 점유율, 2024년과 2030년
- 제품 부문 대시보드
- 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
- 기기
- 시약
- 소프트웨어
제5장 고해상도 용융 분석 시장 : 용도별, 비즈니스 분석
- 용도 시장 점유율, 2024년과 2030년
- 용도 부문 대시보드
- 시장 규모와 예측과 동향 분석, 용도별, 2018-2030년
- 획득 변이 검출/변이 스캔/SNP 타이핑
- 미생물종 동정
- 접합성 검사
- 후생유전학/메틸화 프로파일링과 약제 내성
제6장 고해상도 용융 분석 시장 : 최종 용도별, 비즈니스 분석
- 최종 용도 시장 점유율, 2024년과 2030년
- 최종 용도 부문 대시보드
- 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
- 학술 연구
- 임상 진단
제7장 고해상도 용융 분석 시장 : 지역별, 추정·동향 분석
- 지역별 시장 점유율 분석, 2024년과 2030년
- 지역별 시장 대시보드
- 시장 규모, 예측 동향 분석, 2018-2030년
- 북미
- 국가별, 2018-2030년
- 미국
- 캐나다
- 멕시코
- 유럽
- 국가별, 2018-2030년
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 국가별, 2018-2030년
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
- 라틴아메리카
- 국가별, 2018-2030년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 국가별, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제8장 경쟁 구도
- 참여자 개요
- 기업의 시장 포지션 분석
- 기업 분류
- 전략 매핑
- 기업 개요/상장 기업
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffman-La Roche Ltd.
- Bio Farma
- QIAGEN
- Illumina, Inc.
- Agilent Technologies, Inc.
- BIOMERIEUX
- Meridian Bioscience, Inc.
- Novacyt
- PREMIER Biosoft
- Azura Genomics Inc.
- Canon Medical Systems Corporation
ksm 25.04.16
High Resolution Melting Analysis Market Growth & Trends:
The global high resolution melting analysis market size is expected to reach USD 375.8 million by 2030, growing at a CAGR of 2.7% from 2025 to 2030, according to a new report by Grand View Research Inc. Increasing incidences of cancer, sickle cell anemia, HIV and other STDs are expected to positively reinforce demand for smart and simple molecular diagnostics.
Based on analyzing the disease trends and relatively lower treatment rates suggests that the demand for gene mutation and other genomic tests are expected to increase significantly over the next few years. Recent developments in the field of QPCR, next generation sequencing, genomics and big data analytics have been instrumental in strengthening the precision medicine approach. The U.S. FDA has already approved some of the treatments which are designed to meet the requirements of a specific genetic makeup or the genomic profile of the patient's tumor.
For instance, the U.S FDA has approved a new treatment for cystic fibrosis (CF) in January, 2012. The drug kalydeco was approved for patients reported to have a specific genetic mutation known as "G551D mutation. The number of mutations which can lead to CF is in hundreds, and the G551D mutation is responsible for nearly 4% of the cases in the U.S.
Furthermore, in 2015, the Obama administration has announced the Precision Medicine Initiative with an investment of USD 216 million in the 2016 president's budget. This initiative is expected to positively reinforce the HRM analysis market over the forecast period.
High Resolution Melting Analysis Market Report Highlights:
- Clinical diagnostics is anticipated to be the fastest-growing segment, with a CAGR of 3.1% from 2025 to 2030.
- The detection of acquired mutations/mutation scanning/SNP typing segment held a highest revenue share in 2024.
- In 2024, North America dominated the overall HRM analysis market with a share of nearly 36.0%. Key factors attributed are high disease prevalence rates, presence of large number of academic universities; strong pharmaceutical and biotech industry, presence of large number genetic testing centers, and rapid adoption of novel technologies for improving the healthcare outcomes.
- Asia Pacific high resolution melting analysis market is expected to expand at the fastest CAGR of 4.9% over the forecast period, owing to the high population growth and the increasing number of cancer cases and other chronic diseases leading to high unmet medical needs in the region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. High Resolution Melting Analysis Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
Chapter 4. High Resolution Melting Analysis Market: Product Business Analysis
- 4.1. Product Market Share, 2024 & 2030
- 4.2. Product Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
- 4.5. Reagents
- 4.5.1. Reagents Market, 2018 - 2030 (USD Million)
- 4.6. Software
- 4.6.1. Software Market, 2018 - 2030 (USD Million)
Chapter 5. High Resolution Melting Analysis Market: Application Business Analysis
- 5.1. Application Market Share, 2024 & 2030
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Detection of Acquired Mutations/Mutation Scanning/SNP Typing
- 5.4.1. Detection of Acquired Mutations/Mutation Scanning/SNP Typing Market, 2018 - 2030 (USD Million)
- 5.5. Microbial Species Identification
- 5.5.1. Microbial Species Identification Market, 2018 - 2030 (USD Million)
- 5.6. Zygosity Testing
- 5.6.1. Zygosity Testing Market, 2018 - 2030 (USD Million)
- 5.7. Epigenetics/Methylation Profiling and Drug-Resistant
- 5.7.1. Epigenetics/Methylation Profiling and Drug-Resistant Market, 2018 - 2030 (USD Million)
Chapter 6. High Resolution Melting Analysis Market: End Use Business Analysis
- 6.1. End Use Market Share, 2024 & 2030
- 6.2. End Use Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Academic Research
- 6.4.1. Academic Research Market, 2018 - 2030 (USD Million)
- 6.5. Clinical Diagnostics
- 6.5.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 7. High Resolution Melting Analysis Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America High Resolution Melting Analysis Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Regulatory Framework
- 7.4.2.3. Competitive Insights
- 7.4.2.4. U.S. High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Regulatory Framework
- 7.4.3.3. Competitive Insights
- 7.4.3.4. Canada High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Regulatory Framework
- 7.4.4.3. Competitive Insights
- 7.4.4.4. Mexico High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe High Resolution Melting Analysis Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Regulatory Framework
- 7.5.2.3. Competitive Insights
- 7.5.2.4. Germany High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. UK
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Regulatory Framework
- 7.5.3.3. Competitive Insights
- 7.5.3.4. UK High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Regulatory Framework
- 7.5.4.3. Competitive Insights
- 7.5.4.4. France High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Regulatory Framework
- 7.5.5.3. Competitive Insights
- 7.5.5.4. Italy High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Regulatory Framework
- 7.5.6.3. Competitive Insights
- 7.5.6.4. Spain High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.7. Denmark
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Regulatory Framework
- 7.5.7.3. Competitive Insights
- 7.5.7.4. Denmark High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Regulatory Framework
- 7.5.8.3. Competitive Insights
- 7.5.8.4. Sweden High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.9. Norway
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Regulatory Framework
- 7.5.9.3. Competitive Insights
- 7.5.9.4. Norway High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific High Resolution Melting Analysis Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Regulatory Framework
- 7.6.2.3. Competitive Insights
- 7.6.2.4. Japan High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Regulatory Framework
- 7.6.3.3. Competitive Insights
- 7.6.3.4. China High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Regulatory Framework
- 7.6.4.3. Competitive Insights
- 7.6.4.4. India High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Regulatory Framework
- 7.6.5.3. Competitive Insights
- 7.6.5.4. Australia High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Regulatory Framework
- 7.6.6.3. Competitive Insights
- 7.6.6.4. South Korea High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Regulatory Framework
- 7.6.7.3. Competitive Insights
- 7.6.7.4. Thailand High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America High Resolution Melting Analysis Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Regulatory Framework
- 7.7.2.3. Competitive Insights
- 7.7.2.4. Brazil High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Regulatory Framework
- 7.7.3.3. Competitive Insights
- 7.7.3.4. Argentina High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA High Resolution Melting Analysis Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Regulatory Framework
- 7.8.2.3. Competitive Insights
- 7.8.2.4. South Africa High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Regulatory Framework
- 7.8.3.3. Competitive Insights
- 7.8.3.4. Saudi Arabia High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Regulatory Framework
- 7.8.4.3. Competitive Insights
- 7.8.4.4. UAE High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Regulatory Framework
- 7.8.5.3. Competitive Insights
- 7.8.5.4. Kuwait High Resolution Melting Analysis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Thermo Fisher Scientific Inc.
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Bio-Rad Laboratories, Inc.
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. F. Hoffman-La Roche Ltd.
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Bio Farma
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. QIAGEN
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. Illumina, Inc.
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. Agilent Technologies, Inc.
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. BIOMERIEUX
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. Meridian Bioscience, Inc.
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. Novacyt
- 8.5.10.1. Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
- 8.5.11. PREMIER Biosoft
- 8.5.11.1. Overview
- 8.5.11.2. Financial Performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic Initiatives
- 8.5.12. Azura Genomics Inc.
- 8.5.12.1. Overview
- 8.5.12.2. Financial Performance
- 8.5.12.3. Product Benchmarking
- 8.5.12.4. Strategic Initiatives
- 8.5.13. Canon Medical Systems Corporation
- 8.5.13.1. Overview
- 8.5.13.2. Financial Performance
- 8.5.13.3. Product Benchmarking
- 8.5.13.4. Strategic Initiatives